London—For any patient undergoing cancer treatment, the risk of cognitive impairment is real. But for adolescents and young adults (AYA), the risk may be underappreciated, according to a study presented at the 2019 International Symposium on Oncology Pharmacy Practice.
OCTOBER 15, 2019